Medications While Breastfeeding

The Breastfeeding Medication Dilemma

Breastfeeding is one of the most important things a parent can do for a newborn's health. Breast milk provides ideal nutrition, antibodies, and a range of bioactive compounds that support immune development. Yet many new mothers take medications for chronic conditions, postpartum depression, infections, pain, or other health issues. The concern that a medication might harm a nursing infant leads many women to stop breastfeeding unnecessarily — or to stop taking medications they genuinely need.

The reality is more reassuring than many people realize. Most medications transfer into breast milk at very low levels, and the vast majority are compatible with breastfeeding. The goal of this guide is to give you the tools to evaluate breastfeeding safety thoughtfully, rather than defaulting to "stop breastfeeding" whenever a medication is prescribed.

How Drugs Enter Breast Milk

Breast milk is produced by cells in the alveoli of the mammary glands. Drugs enter breast milk primarily through passive diffusion — they move from areas of higher concentration (blood plasma) to lower concentration (milk) across cell membranes. The driving forces are the same as those governing placental transfer:

• Concentration gradient between plasma and milk
• Lipid solubility — fat-soluble drugs concentrate more easily in the fat-rich portions of milk
• Molecular weight — smaller molecules diffuse more freely
• Ionization state — breast milk is slightly more acidic than plasma, which causes weakly basic drugs to become slightly more ionized (trapped) in milk

Active transport mechanisms also move some drugs into milk, but passive diffusion accounts for most drug transfer.

Key Factors That Determine Infant Exposure

Several drug properties and maternal factors determine how much of a drug actually reaches a nursing infant.

half-lifeHalf-Life

The time required for the plasma concentration of a drug to decrease by 50%. Half-life determines how often a medication needs to be dosed — drugs with shorter half-lives require more frequent dosing

-and-timing-feeds">Half-Life and Timing Feeds

A drug's half-life is the time it takes for its plasma concentration to fall by half. Drugs with short half-lives are cleared from the mother's bloodstream quickly, which means the window of peak drug concentration in milk is brief. For a drug with a 2-hour half-life, waiting 4–6 hours after a dose before breastfeeding can substantially reduce infant exposure. This "pump and dump" or "time the feed" strategy works best for drugs taken infrequently (e.g., a single dose of a pain reliever after a procedure).

Drugs with very long half-lives — measured in days — accumulate more steadily in milk and cannot be easily timed around.

Protein BindingProtein Binding

The reversible binding of drugs to plasma proteins (primarily albumin). Only the unbound (free) fraction of a drug is pharmacologically active. Highly protein-bound drugs can be displaced by other dru

and Transfer

Protein binding refers to the degree to which a drug attaches to proteins in the bloodstream, particularly albumin. Only the free (unbound) fraction of a drug is pharmacologically active and capable of crossing into tissues, including breast milk. A drug that is 99% protein-bound has only 1% of its total concentration available to transfer. High protein binding is generally associated with lower milk transfer.

Understanding Relative Infant Dose

The most useful single number for evaluating breastfeeding safety is the Relative Infant Dose (RID) — the infant's weight-adjusted dose as a percentage of the mother's weight-adjusted dose. It is calculated as:

RID (%) = (Milk concentration × infant milk intake) / (Maternal dose per kg)

An RID below 10% is generally considered acceptable for most medications. Most commonly used drugs have RIDs well below this threshold. For drugs where infant risks are well-characterized and low (such as most antibiotics), an RID of even 20–30% may still be considered acceptable. For drugs where even small doses pose theoretical risks to the infant (such as certain chemotherapy agents), any detectable transfer is a concern.

Commonly Used Medications and Breastfeeding

Pain relievers: Ibuprofen has one of the lowest RIDs of common analgesics and is considered compatible with breastfeeding. Acetaminophen (paracetamol) is also compatible. Codeine requires caution because some infants are ultra-rapid metabolizers of codeine and can reach toxic morphine levels; most guidelines now recommend avoiding codeine in breastfeeding mothers.

Antibiotics: Penicillins, cephalosporins, and azithromycin are considered compatible with breastfeeding. The main concern is not toxicity but alteration of the infant's gut microbiome, which can cause diarrhea. Metronidazole is often cited as a concern; the data are reassuring for standard doses, but some guidelines suggest discarding milk for 12–24 hours after a large single dose.

Antidepressants: SSRIs are among the best-studied antidepressants in lactation. Sertraline consistently shows a very low RID and is generally considered the first-choice antidepressant during breastfeeding. Paroxetine and fluvoxamine also have low RIDs. Fluoxetine has a longer half-life and an active metabolite that can accumulate; it is generally used with more caution, particularly for newborns.

Antihistamines: Older (first-generation) antihistamines like diphenhydramine can cause sedation in infants and may reduce milk supply. Non-sedating second-generation antihistamines like loratadine and cetirizine are preferred.

Hormonal contraceptives: Progestin-only contraceptives (the "mini-pill," Depo-Provera, hormonal IUDs) are generally considered compatible with breastfeeding. Combined estrogen-progestin contraceptives may reduce milk supply, particularly in the early weeks of lactation.

Medications Generally Avoided During Breastfeeding

Some medications are generally avoided because of documented harm, high RIDs, or the availability of safer alternatives:

• Chemotherapy and immunosuppressants — most are contraindicated during breastfeeding
• Radioactive compounds — breastfeeding should be paused for a specified period depending on the compound's half-life
• Ergotamine (used for migraines) — associated with infant toxicity and reduced milk production
• Amiodarone (heart arrhythmia drug) — long half-life, high iodine content, significant infant thyroid risk

Reliable Resources for Breastfeeding Safety

Two evidence-based resources stand above all others for evaluating drug safety during breastfeeding:

LactMed (National Institutes of Health): A free, peer-reviewed database summarizing data on drug levels in breast milk, infant blood levels, and known effects on nursing infants. Updated regularly and freely accessible.

Drugs and Lactation Database (LactMed) via NLM: The same database accessible through the National Library of Medicine's MedlinePlus platform.

Hale's Medications and Mothers' Milk: A comprehensive reference book updated regularly by pharmacologist Thomas Hale, widely used by lactation consultants and healthcare providers.

Avoid relying on the package insert alone. Drug manufacturers routinely recommend against use during breastfeeding as a legal precaution, even when safety data are actually reassuring.

Talking to Your Healthcare Team

When discussing a medication with your provider while breastfeeding:

• Ask specifically whether the drug has been studied in breastfeeding women, not just pregnant women — these are different questions with different answers.
• Ask about the RID if it is known.
• Ask whether the timing of doses relative to feeds could reduce infant exposure.
• Ask whether a safer alternative with better lactation data exists.
• If your provider is uncertain, ask for a referral to a lactation consultant who is knowledgeable about medications, or contact MotherToBaby (a free teratogen information service that covers lactation).

Key Takeaways

• Most medications transfer into breast milk at very low levels and are compatible with breastfeeding.
• Relative Infant Dose (RID) below 10% is generally considered acceptable; most common drugs fall well below this threshold.
• Half-life determines how quickly a drug clears from milk; timing feeds after doses can reduce infant exposure for short-acting drugs.
• Protein binding reduces free drug available for transfer into milk.
• LactMed (free NIH database) is the most accessible evidence-based resource for evaluating specific drugs.
• Do not rely on package inserts alone — they often recommend against breastfeeding as a legal precaution regardless of actual risk.
• Always involve your healthcare provider before stopping a necessary medication or stopping breastfeeding.